Table 3.

Number and Type of Antihypertensive Drugs Dispensed to Women With Chronic Hypertension Treated During Pregnancy at All 3 Trimesters of the Pregnancy and Postpartum

Indication*	1 year before pregnancy		First trimester		Second trimester		Third trimester		Postpartum
	No.	Percentage	No.	Percentage	No.	Percentage	No.	Percentage	No.	Percentage
Contraindicated drug	4563	31.7	1498	10.9	328	2.0	105	0.7	1584	12.8
Nonindicated drug	8684	60.3	7144	51.8	7022	42.6	5013	33.9	4382	35.3
Indicated drug	1143	7.9	5153	37.4	9123	55.4	9661	65.4	6436	51.9
All drugs	14 390	100	13 795	100	16 473	100	14 779	100	12 402	100

^*Angiotensin‐converting enzyme inhibitors, angiotensin II receptor antagonists, and aliskiren were considered contraindicated drugs during pregnancy (formally contraindicated in the second and third trimesters). Methyldopa, nicardipine, labetalol, and nifedipine were considered indicated drugs during pregnancy. All other molecules were considered nonindicated during pregnancy.